← SynDRA
TRICLOSAN
SynDRA canonical compound SYN0002201 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | DNMT1 |
|---|
| Mechanism of action | Enoyl-acyl-carrier protein reductase inhibitor |
|---|
| Indication | first-aid antiseptic |
|---|
| Disease area | infectious disease |
|---|
All known targets
- DNMT1
- CBR1
- ENR
- FabI
- HSPA5
- Malaria fabI
- fabI
- inhA
Mechanisms of action (all sources)
- Enoyl-acyl-carrier protein reductase inhibitor
- antibacterial agent
- Binder
- fabI INHIBITOR
Drug classes
- Anti-Infective Agents
- Anti-Infective Agents, Local
- Antimetabolites
- Fatty Acid Synthesis Inhibitors
- Hypolipidemic Agents
ATC classes
- D08A · ANTISEPTICS AND DISINFECTANTS
- D09A · MEDICATED DRESSINGS
Cross-references
Synonyms
- Cloxifenol
- CH-3565
- DNDI1246774
- NSC-759151
- Aquasept
- Gamophen
- Innoxa
- Manusept
- Skinsan
- Stri-dex cleansing bar
- Tegusept
- Triclosan component of colgate total
- 5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL
- 2,4,4'-Trichloro-2'-hydroxydiphenyl ether
- Irgasan
- Cloxifenolum
- Triclosanum
- Irgasan DP300
- Stri-Dex Face Wash
- Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-
- Lexol 300
- Stri-Dex Cleansing Bar
- 5-Chloro-2-(2,4-dichloro-phenoxy)-phenol
- Triclosanum [INN-Latin]
- DP-300
- Caswell No 186A
- C12H7Cl3O2
- UNII-4NM5039Y5X
- HSDB 7194
- CHEBI:164200
- Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl
- Phenyl ether, 2'-hydroxy-2,4,4'-trichloro-
- EINECS 222-182-2
- CHEMBL849
- EPA
- Cliniclean
- Sapoderm
- TCL
Look up TRICLOSAN in the interactive SynDRA portal →